Biotech

How UK-based BoobyBiome Is Advancing Infant Feeding Harnessing the Power of the Breast Milk Microbiome

BoobyBiome, a UK-based startup headquartered in the Great Ormond Street Institute of Child Health, is on a mission to transform infant health for generations to come. Founded by three female entrepreneurs with expertise in microbiology, neuroscience, chemistry, and biophysics, BoobyBiome is advancing the field of infant feeding by harnessing the power of the breast milk microbiome. Since its inception in 2019, BoobyBiome…

BillionToOne Launches Prenatal Genetics Test BabyPeek that Predicts Non-medical Traits

Molecular diagnostics company BillionToOne (BTO) has recently introduced BabyPeek, an addition to their UNITY Complete test, which offers insight into non-medical traits of unborn babies. BabyPeek provides expecting parents with the opportunity to discover traits such as potential eye and hair color, among others, as early as 10 weeks into pregnancy. By integrating BabyPeek into the UNITY Complete test, BTO hopes to…

Harnessing the Frontier of Biotech: Upstream Manufacturing Process Development

The significance of upstream process development extends beyond the technical realm – it is a strategic imperative for the biotech industry. The efficiency, scalability, and robustness of upstream processes directly influence the cost of goods, production timelines, and ultimately, the accessibility of biologics to patients. As such, continuous improvement and innovation in upstream manufacturing are not merely operational goals, but are central…

23andMe Launches New Genetic Reports on Breast Cancer Risk

23andMe has recently unveiled an initiative aimed at offering deeper insights into the risk of developing breast cancer. The company’s new genetic reports bring forth a new approach to cancer risk prediction, particularly focusing on breast, colorectal, and prostate cancer. Recent studies have underscored a concerning trend: a notable increase in cancer diagnoses among younger individuals. Federal data from the US indicates…

Innovate UK Grant Supports Female-Led Startup Building Diverse Biomarker Database

SökerData, a London-based, female-founded digital health startup, has been awarded a substantial portion of a £6.2 million grant by Innovate UK. The startup is set to advance the field of drug discovery through its innovative biomarker database project, aimed at enhancing disease characterisation and drug development efficiency. With a focus on bridging the gap in clinical trials and improving representation across demographics,…

Gut Health Startup Tiny Health Raises $8.5M in Series A Funding to Expand Beyond Infant and Children’s Health

Tiny Health, the creator of the first at-home gut microbiome test specifically for babies, has raised $8.5 million in a Series A funding round. The round was led by Spero Ventures, contributing to a total of $13 million raised by the company aimed at enhancing gut health innovation. This funding round also saw participation from TheVentureCity, Overwater Ventures, Next Coast Ventures, and…

Invitae Sells Reproductive Health Assets to Natera Amid Financial Challenges

Invitae, a company in medical genetics, announced the completion of its reproductive health assets sale to Natera. This transaction, valued at up to $52.5 million, includes cash, milestone payments, and litigation credits. The assets sold to Natera involve carrier screening and non-invasive prenatal screening services. Ken Knight, President and CEO of Invitae, stated: “Today’s announcement further helps us streamline operations and focus…

Daré Bioscience Receives Grant from Gates Foundation to Develop Biotherapeutic Products for Infant and Women’s Health

Daré Bioscience, a women’s health company, has announced the receipt of a $750K grant from the Bill & Melinda Gates Foundation. This funding is earmarked for the development of bacteria-based live biotherapeutic products, aiming to enhance the health of women and newborns globally. This recent grant follows a previous award of approximately $585K from the foundation, granted to Daré in November 2022…